[HTML][HTML] Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
TP Sheahan, AC Sims, SR Leist, A Schäfer… - Nature …, 2020 - nature.com
Middle East respiratory syndrome coronavirus (MERS-CoV) is the causative agent of a
severe respiratory disease associated with more than 2468 human infections and over 851 …
severe respiratory disease associated with more than 2468 human infections and over 851 …
[PDF][PDF] Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
TP Sheahan, AC Sims, SR Leist, A Schäfer, J Won… - academia.edu
RTV. We utilized a recombinant MERS-CoV engineered to express a reporter
nanoluciferase (MERS-nLUC) for our in vitro antiviral activity assays. To ensure that our …
nanoluciferase (MERS-nLUC) for our in vitro antiviral activity assays. To ensure that our …
[HTML][HTML] Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
TP Sheahan, AC Sims, SR Leist, A Schäfer… - Nature …, 2020 - ncbi.nlm.nih.gov
Middle East respiratory syndrome coronavirus (MERS-CoV) is the causative agent of a
severe respiratory disease associated with more than 2468 human infections and over 851 …
severe respiratory disease associated with more than 2468 human infections and over 851 …
[PDF][PDF] Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
TP Sheahan, AC Sims, SR Leist, A Schäfer, J Won… - apfh.pt
RTV. We utilized a recombinant MERS-CoV engineered to express a reporter
nanoluciferase (MERS-nLUC) for our in vitro antiviral activity assays. To ensure that our …
nanoluciferase (MERS-nLUC) for our in vitro antiviral activity assays. To ensure that our …
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
TP Sheahan, AC Sims, SR Leist, A Schäfer… - Nature …, 2020 - ideas.repec.org
Middle East respiratory syndrome coronavirus (MERS-CoV) is the causative agent of a
severe respiratory disease associated with more than 2468 human infections and over 851 …
severe respiratory disease associated with more than 2468 human infections and over 851 …
[PDF][PDF] Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
TP Sheahan, AC Sims, SR Leist, A Schäfer, J Won… - scholar.archive.org
RTV. We utilized a recombinant MERS-CoV engineered to express a reporter
nanoluciferase (MERS-nLUC) for our in vitro antiviral activity assays. To ensure that our …
nanoluciferase (MERS-nLUC) for our in vitro antiviral activity assays. To ensure that our …
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
TP Sheahan, AC Sims, SR Leist, A Schäfer… - Nature …, 2020 - cdr.lib.unc.edu
Middle East respiratory syndrome coronavirus (MERS-CoV) is the causative agent of a
severe respiratory disease associated with more than 2468 human infections and over 851 …
severe respiratory disease associated with more than 2468 human infections and over 851 …
[PDF][PDF] Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
TP Sheahan, AC Sims, SR Leist, A Schäfer, J Won… - endocare.hu
RTV. We utilized a recombinant MERS-CoV engineered to express a reporter
nanoluciferase (MERS-nLUC) for our in vitro antiviral activity assays. To ensure that our …
nanoluciferase (MERS-nLUC) for our in vitro antiviral activity assays. To ensure that our …
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV.
TP Sheahan, AC Sims, SR Leist… - Nature …, 2020 - search.ebscohost.com
Middle East respiratory syndrome coronavirus (MERS-CoV) is the causative agent of a
severe respiratory disease associated with more than 2468 human infections and over 851 …
severe respiratory disease associated with more than 2468 human infections and over 851 …
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
TP Sheahan, AC Sims, SR Leist… - Nature …, 2020 - econpapers.repec.org
Middle East respiratory syndrome coronavirus (MERS-CoV) is the causative agent of a
severe respiratory disease associated with more than 2468 human infections and over 851 …
severe respiratory disease associated with more than 2468 human infections and over 851 …